Zobrazeno 1 - 10
of 2 030
pro vyhledávání: '"Sansom, O"'
Autor:
Sansom O; CRUK Scotland Institute, Glasgow G61 1BD, UK., Bogani D; Mary Lyon Centre at MRC Harwell, Harwell Campus, Didcot OX11 0RD, UK., Reichenbach L; CRUK Scotland Institute, Glasgow G61 1BD, UK., Wells S; Mary Lyon Centre at MRC Harwell, Harwell Campus, Didcot OX11 0RD, UK.
Publikováno v:
Disease models & mechanisms [Dis Model Mech] 2024 Aug 01; Vol. 17 (8). Date of Electronic Publication: 2024 Aug 30.
Autor:
Domingo E; Department of Oncology, University of Oxford, Oxford, United Kingdom.; CRUK Beatson Institute of Cancer Research, Garscube Estate, Glasgow, United Kingdom., Kelly C; CRUK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., Hay J; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Sansom O; CRUK Beatson Institute of Cancer Research, Garscube Estate, Glasgow, United Kingdom., Maka N; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Oien K; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Iveson T; University of Southampton, Southampton, United Kingdom., Saunders M; The Christie NHS Foundation Trust, Manchester, United Kingdom., Kerr R; Department of Oncology, University of Oxford, Oxford, United Kingdom., Tomlinson I; Department of Oncology, University of Oxford, Oxford, United Kingdom., Edwards J; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Harkin A; CRUK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom., Nowak M; Department of Pathology and Molecular Pathology, Zurich, Switzerland., Koelzer V; Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Pathology and Molecular Pathology, Zurich, Switzerland., Easton A; Department of Oncology, University of Oxford, Oxford, United Kingdom., Boukovinas I; Medical Oncology Unit Department, Bioclinic Oncology Unit of Thessaloniki, Thessaloniki, Greece., Moustou E; Pathology, University Hospital of Heraklion, Crete, Greece., Messaritakis I; Laboratory of Translational Oncology, University of Crete-School of Medicine, Heraklion, Greece., Chondrozoumaki M; Laboratory of Tumor Cell Biology, University of Crete - School of Medicine, Heraklion, Greece., Karagianni M; Laboratory of Translational Oncology, University of Crete-School of Medicine, Heraklion, Greece., Pagès F; INSERM, Laboratory of Integrative Cancer Immunology, Sorbonne Université, Université de Paris Cité, Cordeliers Research Center, Paris, France.; Assistance Publique-Hôpitaux de Paris (AP-HP), Immunomonitoring Platform, Georges Pompidou European Hospital, Paris, France., Arnoux F; VERACYTE, Marseille, France., Lautard C; VERACYTE, Marseille, France., Lovera Y; VERACYTE, Marseille, France., Boquet I; VERACYTE, Marseille, France., Catteau A; VERACYTE, Marseille, France., Galon J; INSERM, Laboratory of Integrative Cancer Immunology, Sorbonne Université, Université de Paris Cité, Cordeliers Research Center, Paris, France.; VERACYTE, Marseille, France., Souglakos I; Laboratory of Translational Oncology, University of Crete-School of Medicine, Heraklion, Greece.; Department of Medical Oncology, University General Hospital of Heraklion, Heraklion, Greece., Church DN; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 20; Vol. 42 (18), pp. 2207-2218. Date of Electronic Publication: 2024 Mar 14.
Autor:
Frei AL; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Life Science Zurich Graduate School, PhD Program in Biomedicine, University of Zurich, Zurich, Switzerland., McGuigan A; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Sinha RRAK; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Jabbar F; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gneo L; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Tomasevic T; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Harkin A; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Iveson T; Southampton University, Southampton, UK., Saunders MP; The Christie NHS Foundation Trust, Manchester, UK., Oien KA; School of Cancer Sciences, University of Glasgow, Glasgow, UK; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Maka N; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Pezzella F; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK., Campo L; Department of Oncology, University of Oxford, Oxford, UK., Browne M; Department of Oncology, University of Oxford, Oxford, UK., Glaire M; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kildal W; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Danielsen HE; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Hay J; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Edwards J; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Sansom O; School of Cancer Sciences, University of Glasgow, Glasgow, UK; Cancer Research UK Beatson Institute of Cancer Research, Glasgow, UK; Cancer Research UK Scotland Centre, Glasgow and Edinburgh, UK., Kelly C; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Tomlinson I; Department of Oncology, University of Oxford, Oxford, UK., Kerr R; Department of Oncology, University of Oxford, Oxford, UK., Kerr D; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK., Domingo E; Department of Oncology, University of Oxford, Oxford, UK; Cancer Research UK Scotland Centre, Glasgow and Edinburgh, UK., Church DN; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: david.church@well.ox.ac.uk., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Oncology, University of Oxford, Oxford, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Feb; Vol. 25 (2), pp. 198-211.
Autor:
Screen M; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK michael.screen@babraham.ac.uk., Matheson LS; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK., Howden AJ; Cell Signalling and Immunology, University of Dundee, Dundee, UK., Strathdee D; Cancer Research UK Beatson Institute, Glasgow, UK., Willis AE; MRC Toxicology Unit, University of Cambridge, Cambridge, UK., Bushell M; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Sansom O; Cancer Research UK Beatson Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Turner M; Immunology Programme, The Babraham Institute, Babraham Research Campus, Cambridge, UK martin.turner@babraham.ac.uk.
Publikováno v:
Life science alliance [Life Sci Alliance] 2023 Nov 27; Vol. 7 (2). Date of Electronic Publication: 2023 Nov 27 (Print Publication: 2024).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Huels, D J1, Sansom, O J1
Publikováno v:
British Journal of Cancer. 6/30/2015, Vol. 113 Issue 1, p1-5. 5p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ali A; Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow UK.; Institute of Pathology and Diagnostic Medicine, Khyber Medical University Peshawar, Pakistan.; Gulf Medical University Ajman, United Arab Emirates., Jamieson NB; Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow UK., Khan IN; Department of Pharmaceutical Sciences, Texas A&M Health Science Center, Joe H. Reynolds Medical Bld, Texas A&M University, College Station United States.; Cancer Cell Culture & Precision Oncomedicine Lab, Institute of Basic Medical Sciences, Khyber Medical University Peshawar, Pakistan., Chang D; Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow UK., Giovannetti E; Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center Amsterdam, The Netherlands.; Cancer Pharmacology Lab, AIRC Start-Up Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa Pisa, Italy., Funel N; Cancer Pharmacology Lab, AIRC Start-Up Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa Pisa, Italy., Frampton AE; Department of Surgery & Cancer, Imperial College, Hammersmith Hospital Campus Du Cane Road, London, UK.; Department of Hepato-Pancreato-Biliary (HPB) Surgery, Royal Surrey County Hospital Egerton Road, Guildford, Surrey, GU2 7XX, UK.; Department of Clinical and Experimental Medicine, Faculty of Health and Medical Science, University of Surrey Guildford, Surrey, UK., Morton J; Beatson Institute for Cancer Research, University of Glasgow UK., Sansom O; Beatson Institute for Cancer Research, University of Glasgow UK., Evans TRJ; CR-UK Beatson Institute, University of Glasgow Glasgow, UK., Duthie F; Department of Pathology, Laboratory Medicine Building, Queen Elizabeth University Hospital Greater Glasgow & Clyde NHS., McKay CJ; West of Scotland Pancreatic Unit and Glasgow Royal Infirmary Alexandra Parade, Glasgow., Samra J; Department of Upper Gastrointestinal Surgery, Royal North Shore Hospital Pacific Highway St Leonards, Australia., Gill AJ; Sydney Medical School, University of Sydney Sydney, Australia.; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, and Health Pathology Department of Anatomical Pathology, Royal North Shore Hospital St Leonards, NSW, Australia.; The Kinghorn Cancer Centre, The Garvan Institute of Medical Research Darlinghurst, Sydney, Australia.; The Australian Pancreatic Genome Initiative Darlinghurst NSW 2010, Australia., Biankin A; Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow UK., Oien KA; Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow UK.; Department of Pathology, Laboratory Medicine Building, Queen Elizabeth University Hospital Greater Glasgow & Clyde NHS.
Publikováno v:
American journal of cancer research [Am J Cancer Res] 2022 Dec 15; Vol. 12 (12), pp. 5668-5683. Date of Electronic Publication: 2022 Dec 15 (Print Publication: 2022).
Publikováno v:
Disease models & mechanisms [Dis Model Mech] 2014 Aug; Vol. 7 (8), pp. 937-40.